View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
October 20, 2011

Spineology interbody fusion system wins FDA nod

Spineology has received US Food and Drug Administration (FDA ) clearance for its new Rampart line of Interbody fusion implants.

Spineology has received US Food and Drug Administration (FDA ) clearance for its new Rampart line of Interbody fusion implants.

The interbody fusion system is incorporated with implantation equipment designed to enhance a surgeon’s ability to position the implant within the disc space.

The Rampart line will feature a variety of implant configurations, lengths and heights providing the surgeon with several options to fit patient needs.

The company is committed to increasing procedural efficiency, reducing surgical morbidity and accelerating patient recovery.

 

 

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Hospital Management